Task: Answer the multiple-choice question.
Question: Which drug exhibits a 7.703% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] C=CCNC(=O)Cc1ccc(S(=O)(=O)N2CCOCC2)s1
[b] Cc1nc(SCC(=O)c2ccc(Cl)cc2)c([N+](=O)[O-])[nH]1
[c] CCc1nc(C)c(C(=O)N2CCCC(C(=O)Nc3cccc(-c4cccc(C)c4)c3)C2)o1
Answer: a. C=CCNC(=O)Cc1ccc(S(=O)(=O)N2CCOCC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNC(=O)Cc1ccc(S(=O)(=O)N2CCOCC2)s1
C=CCNC(=O)Cc1ccc(S(=O)(=O)N2CCOCC2)s1
2-(5-morpholin-4-ylsulfonylthiophen-2-yl)-N-prop-2-enylacetamide